The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program

被引:7
|
作者
Roman, M. [1 ,2 ]
Skaane, P. [3 ]
Hofvind, S. [1 ,4 ]
机构
[1] Canc Registry Norway, N-0403 Oslo, Norway
[2] Oslo Univ Hosp, Dept Women & Childrens Hlth, Oslo, Norway
[3] Univ Oslo, Dept Radiol, Oslo Univ Hosp Ullevaal, Oslo, Norway
[4] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Oslo, Norway
关键词
Breast neoplasms; Mass screening; Mammography; False positive reactions; Predictive value of tests; CORE NEEDLE-BIOPSY; DIGITAL MAMMOGRAPHY; FINE-NEEDLE; CONSEQUENCES; PERFORMANCE; ACCURACY; LESIONS; RECALL; IMPACT;
D O I
10.1016/j.ejrad.2014.05.038
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Recall for assessment in mammographic screening entails an inevitable number of false-positive screening results. This study aimed to investigate the variation in the cumulative risk of a false positive screening result and the positive predictive value across the screening centres in the Norwegian Breast Cancer Screening Program. Methods: We studied 618,636 women aged 50-69 years who underwent 2,090,575 screening exams (1996-2010. Recall rate, positive predictive value, rate of screen-detected cancer, and the cumulative risk of a false positive screening result, without and with invasive procedures across the screening centres were calculated. Generalized linear models were used to estimate the probability of a false positive screening result and to compute the cumulative false-positive risk for up to ten biennial screening examinations. Results: The cumulative risk of a false-positive screening exam varied from 10.7% (95% CI: 9.4-12.0%) to 41.5% (95% CI: 34.1-48.9%) across screening centres, with a highest to lowest ratio of 3.9 (95% CI:3.7-4.0). The highest to lowest ratio for the cumulative risk of undergoing an invasive procedure with a benign outcome was 4.3 (95% CI: 4.0-4.6). The positive predictive value of recall varied between 12.0% (95% CI: 11.0-12.9%) and 19.9% (95% CI: 18.3-21.5%), with a highest to lowest ratio of 1.7 (95% CI: 1.5-1.9). Conclusions: A substantial variation in the performance measures across the screening centres in the Norwegian Breast Cancer Screening Program was identified, despite of similar administration, procedures, and quality assurance requirements. Differences in the readers' performance is probably of influence for the variability. This results underscore the importance of continuous surveillance of the screening centres and the radiologists in order to sustain and improve the performance and effectiveness of screening programs. (C)2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1639 / 1644
页数:6
相关论文
共 50 条
  • [41] False-positive recalls in the prospective Malmo Breast Tomosynthesis Screening Trial
    Johnson, Kristin
    Olinder, Jakob
    Rosso, Aldana
    Andersson, Ingvar
    Lang, Kristina
    Zackrisson, Sophia
    EUROPEAN RADIOLOGY, 2023, 33 (11) : 8089 - 8099
  • [42] False-positive recalls in the prospective Malmö Breast Tomosynthesis Screening Trial
    Kristin Johnson
    Jakob Olinder
    Aldana Rosso
    Ingvar Andersson
    Kristina Lång
    Sophia Zackrisson
    European Radiology, 2023, 33 : 8089 - 8099
  • [43] Consequences of False-Positive Screening Mammograms
    Tosteson, Anna N. A.
    Fryback, Dennis G.
    Hammond, Cristina S.
    Hanna, Lucy G.
    Grove, Margaret R.
    Brown, Mary
    Wang, Qianfei
    Lindfors, Karen
    Pisano, Etta D.
    JAMA INTERNAL MEDICINE, 2014, 174 (06) : 954 - 961
  • [44] Psychosocial consequences among women with false-positive results after mammography screening in Norway
    Solbjor, Marit
    Forsmo, Siri
    Skolbekken, John-Arne
    Siersma, Volkert
    Brodersen, John
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2018, 36 (04) : 380 - 389
  • [45] Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy)
    Squillace, Lorena
    Pizzi, Lorenzo
    Rallo, Flavia
    Bazzani, Carmen
    Saguatti, Gianni
    Mezzetti, Francesca
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort
    Miglioretti, Diana L.
    Abraham, Linn
    Sprague, Brian L.
    Lee, Christoph I.
    Bissell, Michael C. S.
    Ho, Thao-Quyen H.
    Bowles, Erin J. A.
    Henderson, Louise M.
    Hubbard, Rebecca A.
    Tosteson, Anna N. A.
    Kerlikowske, Karla
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (10) : 1297 - 1307
  • [47] Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations
    Kregting, Lindy M.
    van Ravesteyn, Nicolien T.
    Chootipongchaivat, Sarocha
    Heijnsdijk, Eveline A. M.
    Otten, Johannes D. M.
    Broeders, Mireille J. M.
    de Koning, Harry J.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (02) : 312 - 319
  • [48] Improving computer-aided detection assistance in breast cancer screening by removal of obviously false-positive findings
    Mordang, Jan-Jurre
    Gubern-Merida, Albert
    Bria, Alessandro
    Tortorella, Francesco
    den Heeten, Gerard
    Karssemeijer, Nico
    MEDICAL PHYSICS, 2017, 44 (04) : 1390 - 1401
  • [49] Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program
    Hofvind, Solveig
    Roman, Marta
    Sebuodegard, Sofie
    Falk, Ragnhild S.
    JOURNAL OF MEDICAL SCREENING, 2016, 23 (04) : 203 - 209
  • [50] Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases
    Arnaud Seigneurin
    C. Exbrayat
    J. Labarère
    P. Delafosse
    F. Poncet
    M. Colonna
    Breast Cancer Research and Treatment, 2011, 127 : 221 - 228